236 related articles for article (PubMed ID: 16719822)
1. Topical imiquimod: mechanism of action and clinical applications.
Vidal D
Mini Rev Med Chem; 2006 May; 6(5):499-503. PubMed ID: 16719822
[TBL] [Abstract][Full Text] [Related]
2. Imiquimod: a review.
Gupta AK; Browne M; Bluhm R
J Cutan Med Surg; 2002; 6(6):554-60. PubMed ID: 12362256
[TBL] [Abstract][Full Text] [Related]
3. Imiquimod in dermatology: an overview.
Hanna E; Abadi R; Abbas O
Int J Dermatol; 2016 Aug; 55(8):831-44. PubMed ID: 27387373
[TBL] [Abstract][Full Text] [Related]
4. [New perspective in immunotherapy: local imiquimod treatment].
Kemény L; Nagy N
Orv Hetil; 2010 May; 151(19):774-83. PubMed ID: 20427260
[TBL] [Abstract][Full Text] [Related]
5. Topical imiquimod: a review of its use in genital warts.
Perry CM; Lamb HM
Drugs; 1999 Aug; 58(2):375-90. PubMed ID: 10473026
[TBL] [Abstract][Full Text] [Related]
6. Viral and nonviral uses of imiquimod: a review.
Gupta AK; Cherman AM; Tyring SK
J Cutan Med Surg; 2004; 8(5):338-52. PubMed ID: 15868314
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory and pharmacologic properties of imiquimod.
Sauder DN
J Am Acad Dermatol; 2000 Jul; 43(1 Pt 2):S6-11. PubMed ID: 10861101
[TBL] [Abstract][Full Text] [Related]
8. Imiquimod cream in the treatment of actinic keratoses.
Persaud A; Lebwohl M
J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S236-9. PubMed ID: 12271285
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of porokeratosis with topical imiquimod in 2 immunosuppressed cases.
Erbagci Z; Tuncel AA; Erbagci I
J Drugs Dermatol; 2006; 5(7):668-71. PubMed ID: 16865875
[TBL] [Abstract][Full Text] [Related]
10. The use of topical imiquimod for the treatment of actinic keratosis: a status report.
Del Rosso JQ
Cutis; 2005 Oct; 76(4):241-8. PubMed ID: 16315560
[TBL] [Abstract][Full Text] [Related]
11. Current and potential uses of imiquimod.
Chang YC; Madkan V; Cook-Norris R; Sra K; Tyring S
South Med J; 2005 Sep; 98(9):914-20. PubMed ID: 16217984
[TBL] [Abstract][Full Text] [Related]
12. Imiquimod applied topically: A novel immune response modifier.
Tyring S
Skin Therapy Lett; 2001 Mar; 6(6):1-4. PubMed ID: 11298484
[TBL] [Abstract][Full Text] [Related]
13. Topical imiquimod.
Pearson GW; Langley RG
J Dermatolog Treat; 2001 Mar; 12(1):37-40. PubMed ID: 12171687
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy and safety of 5% imiquimod cream in external genital warts: a 6 month follow-up evaluation].
Vexiau D; Decuypère L; Moyse D; Aractingi S
Ann Dermatol Venereol; 2005 Nov; 132(11 Pt 1):845-51. PubMed ID: 16327713
[TBL] [Abstract][Full Text] [Related]
15. Treatment of facial verrucae with topical imiquimod cream in a patient with human immunodeficiency virus.
Cutler K; Kagen MH; Don PC; McAleer P; Weinberg JM
Acta Derm Venereol; 2000; 80(2):134-5. PubMed ID: 10877136
[TBL] [Abstract][Full Text] [Related]
16. Imiquimod 5% cream for actinic keratosis.
Perras C
Issues Emerg Health Technol; 2004 Sep; (61):1-4. PubMed ID: 15382379
[TBL] [Abstract][Full Text] [Related]
17. Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream.
Torres A; Storey L; Anders M; Miller RL; Bulbulian BJ; Jin J; Raghavan S; Lee J; Slade HB; Birmachu W
J Transl Med; 2007 Jan; 5():7. PubMed ID: 17257431
[TBL] [Abstract][Full Text] [Related]
18. Clinical effect of imiquimod 5% cream in the treatment of actinic keratosis.
Persaud AN; Shamuelova E; Sherer D; Lou W; Singer G; Cervera C; Lamba S; Lebwohl MG
J Am Acad Dermatol; 2002 Oct; 47(4):553-6. PubMed ID: 12271300
[TBL] [Abstract][Full Text] [Related]
19. Treatment of genital warts with an immune-response modifier (imiquimod).
Beutner KR; Spruance SL; Hougham AJ; Fox TL; Owens ML; Douglas JM
J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):230-9. PubMed ID: 9486679
[TBL] [Abstract][Full Text] [Related]
20. Innovative uses of imiquimod.
Vender RB; Goldberg O
J Drugs Dermatol; 2005; 4(1):58-63. PubMed ID: 15696986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
